Atlas Trials

Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161

Clinical trial NCT04228406 · UNKNOWN

Trial details

NCT number
NCT04228406
Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorC-Met Mutation-Related Tumors
Start date
2019-07-01
Primary completion
2020-09-30
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.